From:
$13.60
Prescription required
Olanzapine (Zyprexa): Uses, Dosage, Side Effects, and More
Reviewed by:
From:
$13.60
Prescription required
Olanzapine is a second-generation (atypical) antipsychotic belonging to the thienobenzodiazepine class, available in conventional film-coated tablets and orally disintegrating tablets (ODTs). It is primarily indicated for the treatment of schizophrenia and acute manic or mixed episodes associated with Bipolar I Disorder. It is also used in combination with fluoxetine for treatment-resistant depression. Olanzapine works by antagonizing dopamine D₂ and serotonin 5-HT₂A receptors, among others, to control both positive and negative symptoms of psychotic and affective disorders. It is approved for use in adults and adolescents aged 13 to 17 years for certain indications.
Your Prescription
Ready to Fill
Drug Facts
Generic name
Olanzapine
Brand names
Zyprexa, Zyprexa Zydis
Drug type
Second-generation (atypical) antipsychotic; thienobenzodiazepine class
Controlled substance
No
Dosage forms
Conventional film-coated tablets; Orally disintegrating tablets (ODT)
Typical dosage
- Schizophrenia (Adults): 5–10 mg once daily initially; maintenance 10–20 mg once daily
- Bipolar Mania (Adults, Monotherapy): 10–15 mg once daily; maximum 20 mg once daily
- Adolescents (Ages 13–17): 2.5–5 mg once daily initially; maximum 20 mg once daily
- Geriatric patients: Starting dose typically 2.5 mg once daily
Basics
What is Olanzapine?
Olanzapine is an oral, synthetic prescription psychotropic medication belonging to the thienobenzodiazepine class. It functions as a second-generation (atypical) antipsychotic, demonstrating a broad neurochemical footprint that targets both positive and negative symptoms of psychotic and affective disorders.
Olanzapine is engineered across two distinct solid oral delivery vehicles designed to enhance compliance and provide deployment options based on patient agitation or swallowing limitations:
Conventional Film-Coated Tablet
- Available strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg
- Primary patient target: Standard psychiatric maintenance
- Administration: Swallowed whole with water; absorbed uniformly across the gastrointestinal tract
Orally Disintegrating Tablet (ODT)
- Available strengths: 5 mg, 10 mg, 15 mg, 20 mg
- Primary patient target: Non-compliant patients, individuals with dysphagia, or acute agitation
- Administration: Dissolves rapidly on the tongue via saliva within seconds; can be swallowed without water
Indications
What is Olanzapine used for?
Clinically, olanzapine tablets are indicated for the:
- Treatment of Schizophrenia: In adults and adolescents aged 13 to 17 years, to control acute psychotic episodes and maintain long-term clinical stability.
- Acute Treatment of Manic or Mixed Episodes associated with Bipolar I Disorder: Indicated as monotherapy or as an adjunct to lithium or valproate in adults and adolescents aged 13 to 17 years.
- Maintenance Treatment of Bipolar I Disorder: To prolong the intervals between manic, depressive, or mixed relapses.
- Treatment of Treatment-Resistant Depression (TRD): Deployed strictly in combination with oral fluoxetine (Symbyax or co-administered components) for adults whose major depressive disorder has failed to respond to two separate trials of alternative antidepressants.
Because olanzapine exhibits high affinity for metabolic and histaminergic receptor pathways, it carries significant safety concerns regarding rapid weight gain, severe dyslipidemia, and altered glucose homeostasis.
Mechanism
How does Olanzapine work?
Pharmacodynamics and Multi-Receptor Affinity
The precise molecular neurobiology of olanzapine relies on a high-affinity, complex balancing act across multiple central nervous system monoamine receptor networks. Unlike first-generation antipsychotics (like haloperidol), which lock onto dopamine receptors exclusively, olanzapine operates as a potent serotonin-dopamine antagonist:
- Serotonin 5-HT₂A Antagonism: Olanzapine exhibits its highest relative binding affinity at cortical serotonin 5-HT₂A receptors. Blocking these sites disinhibits and increases dopamine release in the prefrontal cortex, which is clinically linked to the alleviation of negative symptoms (such as flat affect, social withdrawal, and avolition) and improved cognitive execution.
- Dopamine D₂ Antagonism: Simultaneously, it acts as a moderate, competitive antagonist at post-synaptic dopamine D₂ receptors, concentrated heavily within the mesolimbic and mesocortical reward tracts. This dampens overactive dopaminergic transmission, effectively suppressing positive psychotic symptoms (including acute hallucinations, structural delusions, and conceptual disorganization). Because its D₂ binding profile is transient and easily displaced by endogenous dopamine (“fast dissociation kinetics”), it carries a significantly lower risk of inducing extrapyramidal side effects (EPS) or tardive dyskinesia compared to typical agents.
- Secondary Receptor Footprint: Olanzapine also acts as a highly potent antagonist at Histamine H₁ receptors (driving severe somnolence and weight gain), Muscarinic M₁ receptors (causing classic anticholinergic side effects), and Alpha-1 (α₁) adrenergic receptors (potentially inducing orthostatic hypotension).
Pharmacokinetics
- Absorption: Following oral administration of either the conventional tablet or the ODT, olanzapine is absorbed completely and reaches peak plasma concentration (Tmax) within 6 hours. The ODT is bioequivalent to the conventional tablet and achieves identical systemic exposure (AUC), as the dissolved drug is ultimately swallowed and absorbed via the gastric mucosa. Absorption kinetics are entirely unaffected by food.
- Metabolism: Undergoes extensive first-pass hepatic biotransformation. It is metabolized primarily via direct glucuronidation by the UGT1A4 enzyme system and, secondarily,n via the CYP1A2 pathway into its primary inactive metabolite, 10-N-glucuronide. It does not heavily rely on CYP2D6 networks.
- Elimination: Exhibits a prolonged terminal elimination half-life, averaging 21 to 54 hours (mean ~30 hours) in adults, safely supporting once-daily dosing. Clearance is statistically 30% slower in females compared to males due to metabolic variations, and significantly accelerated in active tobacco smokers due to smoke-induced upregulation of the CYP1A2 enzyme. It is excreted as inactive metabolites via the urine (~57%) and feces (~30%).
Dosage
Olanzapine Dosages & Administration
Standard Psychiatric Dosing Protocols
Dosing should be highly individualized, typically initiated at low thresholds and titrated upward based on clinical presentation:
- Schizophrenia (Adults): Initiate at a baseline strength of 5 mg to 10 mg orally once daily, targeting a standard therapeutic maintenance range of 10 mg to 20 mg once daily. Dosage adjustments should occur in increments of 5 mg, with intervals of no less than 24 hours.
- Bipolar Mania (Adult Monotherapy): Begin at 10 mg to 15 mg orally once daily, titrating as clinically required up to a maximum safety ceiling of 20 mg once daily.
- Adolescent Titration (Ages 13 to 17): Initiate at a conservative threshold of 2.5 mg to 5 mg orally once daily, titrating carefully up to a maintenance ceiling of 20 mg daily. Adolescents exhibit a significantly higher vulnerability to drug-induced weight gain and hyperprolactinemia than adults.
Strict Administration Guidelines
- The ODT Peel Technique: Orally disintegrating tablets must be handled with clean, completely dry hands. Do not push the tablet directly through the foil backing, as the fragile matrix can crush. Instead, peel open the outer blister foil, gently remove the tablet, place it immediately on top of the tongue, allow it to dissolve completely, and swallow with saliva. Water is entirely optional.
- The Behavioral Timing Rule: Due to its potent H₁-mediated sedative effect, olanzapine should ideally be administered once daily at bedtime in the evening to align peak drug concentrations with sleep cycles and mitigate daytime drowsiness.
Get The Right Dose For Less
Why pay retail prices for the same medication?
At Invictus, we source directly from trusted, FDA-approved manufacturers to keep your costs low without sacrificing quality. Whether you need a one-time fill or regular refills, our transparent pricing makes it easy to save every day.
Side Effects
Olanzapine Side Effects and Risks
Severe Metabolic Syndrome (Weight Gain, Hyperglycemia, and Dyslipidemia)
Olanzapine carries one of the highest risks for inducing profound, rapid-onset metabolic syndrome among all atypical antipsychotics. This is driven by concurrent H₁ and 5-HT₂C receptor blockades that disrupt central satiety signaling:
- Weight Gain: Patients can experience massive increases in adiposity, occasionally gaining 10% or more of their baseline body weight within the initial 3 months of therapy.
- Hyperglycemia and Diabetes: Olanzapine can severely impair peripheral insulin sensitivity and blunt pancreatic beta-cell function. This can precipitate new-onset Type 2 Diabetes Mellitus, severe ketoacidosis, hyperosmolar comas, and death.
- Dyslipidemia: Drives sharp, dangerous spikes in fasting total cholesterol, LDL particles, and serum triglycerides.
- Biochemical Monitoring Protocol: Fasting blood glucose, hemoglobin A1c, body weight, waist circumference, and a complete fasting lipid panel must be checked at baseline, at 4 weeks, 12 weeks, and quarterly or annually thereafter.
Cerebrovascular and Mortality Hazards in Elderly Dementia
The Dementia Warning: Olanzapine is not approved for the treatment of dementia-related psychosis. Large-scale clinical trials demonstrated that elderly patients with dementia-related psychosis treated with atypical antipsychotics exhibit a significant, multi-fold increase in the risk of cerebrovascular accidents (strokes, TIAs) and overall mortality secondary to cardiac events or infectious pneumonia.
Neuroleptic Malignant Syndrome (NMS)
A rare, idiosyncratic, but life-threatening neurological emergency linked to central dopamine blockade:
- Clinical Presentation: Marked by hyperpyrexia (extreme high fever), severe generalized “lead-pipe” muscle rigidity, altered mental status (confusion, delirium), and profound autonomic instability (volatile blood pressure, severe tachycardia, diaphoresis).
- Clinical Action: At the first clinical sign of NMS, olanzapine must be discontinued immediately and permanently. Initiate aggressive cooling protocols, intravenous hydration, and supportive pharmacotherapy (such as dantrolene or bromocriptine) within an intensive care setting.
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
A rare but critical systemic hypersensitivity flare:
- Symptoms: Presents as a widespread cutaneous rash accompanied by an unexplained high fever, generalized lymphadenopathy, and multi-organ inflammation (eosinophilic hepatitis, nephritis, or myocarditis). Discontinue olanzapine permanently if suspected.
Orthostatic Hypotension and Syncope
By antagonizing alpha-1 adrenergic receptors, olanzapine can cause significant blood pressure drops upon standing, increasing the risk of severe falls. This manifests predominantly during the initial 1 to 2 weeks of therapy or following aggressive upward dose escalations.
Common Adverse Reactions
The most frequent side effects documented across large-scale registries include:
- Somnolence, sedation, and daytime sluggishness (affecting up to 35% of patients)
- Profound weight gain and increased appetite
- Xerostomia (dry mouth) and co-administration, increasing the risk of severe falls (anticholinergic receptors
- Dizziness and orthostatic lightheadedness
- Mild, transient extrapyramidal symptoms or tremors
Interactions
Olanzapine Interactions
- Potent CYP1A2 Inducers (Active Tobacco Smoking, Carbamazepine): Inhaling tobacco smoke or co-administering carbamazepine strongly induces the hepatic CYP1A2 enzyme pathway. This accelerates the clearance of olanzapine, reducing its systemic plasma levels by approximately 30% to 40%. If a patient stabilizes on a high dose of olanzapine while smoking, and subsequently stops smoking abruptly, their CYP1A2 activity will drop, causing olanzapine levels to spike dangerously and risking acute toxicity.
- Potent CYP1A2 Inhibitors (Fluvoxamine, Ciprofloxacin): These agents block the primary hepatic breakdown of olanzapine, significantly increasing its maximum blood concentrations (Cmax) and multiplying metabolic and sedative side effects. Preemptive downward olanzapine dose reductions are clinically mandatory.
- Central Nervous System (CNS) Depressants and Alcohol: Alcohol, benzodiazepines (such as lorazepam), and sedating antihistamines synergize with olanzapine’s histaminergic sedating properties, dramatically increasing the risk of respiratory depression, severe orthostatic syncope, and profound psychomotor impairment.
Contraindications
Additional Considerations
Pregnancy and Neonatal Coordination
- Fetal Risk Profile: Large-scale epidemiological registries have not demonstrated a clear, elevated risk of structural fetal malformations following maternal olanzapine use. It crosses the placental barrier readily.
- Neonatal Extrapyramidal / Withdrawal Syndrome: Neonates exposed to antipsychotics, including olanzapine, during the third trimester of pregnancy are at risk for developing post-delivery extrapyramidal or withdrawal symptoms. These present as neonatal agitation, hypertonia, hypotonia, muscle tremors, somnolence, and respiratory distress. These symptoms are self-limiting but may require extended neonatal ICU observation. Olanzapine should be used during gestation only if the potential psychiatric benefit to the mother strictly justifies the risk to the newborn.
Lactation
Olanzapine is excreted into human breast milk in low quantities. Clinical registries suggest the infant receives an exposure equivalent to less than 1% of the maternal dose. While generally well tolerated, the nursing infant must be closely monitored for signs of excessive sedation, poor feeding, lethargy, or changes in developmental milestones.
Geriatric Care
Older adults over the age of 65 exhibit a significantly higher vulnerability to drug-induced orthostatic hypotension, advanced anticholinergic side effects (which can induce or worsen cognitive impairment, severe constipation, and urinary retention), and age-related hepatic clearance drops. Dosing selections must be highly conservative, typically starting at 2 well 5 mg daily, paired with regular metabolic monitoring and pressure tracking.
Ready to Start Saving?
No one should overpay for safe, effective medication. By cutting out middlemen and working directly with trusted, FDA-approved manufacturers, Invictus offers the same high-quality medicines you’d find at big retail pharmacies—at a fraction of the price.
Whether you choose brand-name or generic, we’ll deliver it quickly, affordably, and right to your door. Maybe that’s why most patients who switch to Invictus never look back.
Frequently Asked Questions (FAQs)
Didn’t see the answers you’re looking for in this article? Check out this comprehensive FAQ for more details.
Administration & Dosage
How often you should take olanzapine tablets depends on the condition being treated and your healthcare provider’s prescribed regimen. Olanzapine is commonly taken once daily, although the dose and timing may vary depending on symptom control and side effects. Your healthcare provider may adjust the dose gradually based on your response, overall health, and treatment goals.
Olanzapine tablets are generally taken by mouth with water and may usually be taken with or without food. Some individuals prefer taking olanzapine in the evening because the medication can cause drowsiness or sedation. Taking olanzapine consistently at the same time each day may help maintain stable medication levels and improve treatment adherence.
How long you take olanzapine depends on the psychiatric condition being treated, symptom stability, and your overall mental health treatment plan. Some individuals may require long-term treatment for schizophrenia or bipolar disorder under psychiatric supervision. Your healthcare provider may periodically reassess symptom control, side effects, and ongoing treatment needs during therapy.
If you miss a dose of olanzapine, you should generally take it when you remember unless it is close to the time for your next scheduled dose. Taking extra doses to make up for a missed dose is usually not recommended unless specifically instructed by your healthcare provider. Missing repeated doses may affect symptom stability and treatment effectiveness.
Yes, olanzapine tablets are commonly taken at night because the medication may cause drowsiness or sedation in some individuals. Evening dosing may help reduce daytime sleepiness and improve tolerability for certain people. Your healthcare provider will determine the dosing schedule that best fits your symptoms and side effect profile.
Uses & Mechanism of Action
Olanzapine is used to treat schizophrenia and bipolar disorder and may also be used in certain other psychiatric treatment plans under healthcare supervision. The medication may help improve symptoms such as hallucinations, disorganized thinking, mood instability, agitation, and manic episodes. Treatment plans are individualized based on psychiatric history and symptom severity.
Olanzapine works by affecting neurotransmitters in the brain, particularly dopamine and serotonin, which are involved in mood, behavior, and perception. By helping regulate these signaling systems, olanzapine may reduce psychotic symptoms and stabilize mood in certain psychiatric conditions.
Yes, olanzapine is an atypical antipsychotic medication. Atypical antipsychotics work by altering dopamine and serotonin activity in the brain to help manage symptoms associated with schizophrenia, bipolar disorder, and related psychiatric conditions. Olanzapine is commonly prescribed under psychiatric supervision as part of a broader mental health treatment plan.
How long olanzapine takes to work depends on the condition being treated and individual response to therapy. Some individuals may notice early improvements in sleep, agitation, or mood within days, while fuller psychiatric symptom improvement may take several weeks. Your healthcare provider may monitor your treatment response and adjust the dose gradually over time.
Side Effects & Safety
Yes, olanzapine may help manage symptoms associated with bipolar disorder, including manic or mixed episodes and mood instability. In some treatment plans, olanzapine may also be used alongside other psychiatric medications depending on symptom severity and treatment response. Your healthcare provider will determine whether olanzapine is appropriate for your condition.
Yes, weight gain is one of the more commonly reported side effects of olanzapine. The medication may affect appetite, metabolism, and energy balance in some individuals, potentially contributing to increased body weight over time. Your healthcare provider may monitor weight, blood sugar, and metabolic health during treatment.
Yes, olanzapine can cause drowsiness or sedation, particularly when treatment first begins or after dose increases. Some individuals may feel sleepy, fatigued, or less alert during therapy. Your healthcare provider may recommend evening dosing if sedation becomes bothersome during the day.
Olanzapine may be appropriate for long-term use under psychiatric supervision when the benefits of symptom control outweigh potential risks. Long-term treatment often involves monitoring for metabolic changes, movement-related side effects, and overall mental health stability. Your healthcare provider may periodically reassess ongoing treatment needs during therapy.
Yes, olanzapine can affect blood sugar levels and may increase the risk of high blood sugar or diabetes in some individuals. Weight gain and metabolic changes associated with atypical antipsychotics may contribute to this risk. Your healthcare provider may monitor blood glucose and metabolic markers during treatment.
Interactions & Contraindications
Yes, dizziness can occur while taking olanzapine, particularly when standing up quickly or during early treatment adjustments. The medication may affect blood pressure and central nervous system activity in some individuals. Your healthcare provider may recommend caution with driving or activities requiring alertness until you know how the medication affects you.
Yes, olanzapine can interact with several medications, including sedatives, antidepressants, blood pressure medications, and drugs that affect liver enzyme metabolism. These interactions may increase drowsiness, dizziness, or changes in medication levels. Your healthcare provider and pharmacist should carefully review your medication list before treatment begins.
Olanzapine may not be appropriate for individuals with certain severe medication allergies or specific medical conditions requiring caution with antipsychotic therapy. People with diabetes, cardiovascular disease, seizure disorders, or dementia-related psychosis may require careful evaluation before treatment. Your healthcare provider will review your medical and psychiatric history before prescribing olanzapine.
Alcohol is generally discouraged while taking olanzapine because combining the two may increase drowsiness, dizziness, impaired coordination, and reduced alertness. Alcohol may also interfere with psychiatric symptom management in some individuals. Your healthcare provider may recommend avoiding or limiting alcohol during treatment.
Yes, olanzapine may sometimes be combined with antidepressants under psychiatric supervision depending on the condition being treated. Combination therapy may help address complex mood or psychiatric symptoms in certain individuals. Your healthcare provider will determine the safest and most appropriate medication combination for your situation.
Olanzapine is generally used cautiously during pregnancy because treatment decisions require balancing psychiatric stability with potential medication risks. Your healthcare provider will carefully evaluate the benefits and risks before recommending olanzapine during pregnancy. Monitoring and treatment adjustments may sometimes be necessary during pregnancy.
Generic & Alternatives
Yes, olanzapine is widely available as a generic medication. Generic olanzapine contains the same active ingredient as brand-name versions and is considered therapeutically equivalent. Availability may vary depending on pharmacy supply and dosage form.
Alternatives to olanzapine may include other atypical antipsychotics, mood stabilizers, or psychiatric medications depending on the condition being treated. The most appropriate alternative depends on the symptom profile, side-effect tolerance, metabolic risk, and previous treatment response. Your healthcare provider will determine the best option for your needs.
Olanzapine and quetiapine are both atypical antipsychotics used to treat schizophrenia and bipolar disorder, but they differ in side effect profiles, sedation levels, and metabolic effects. Some individuals may tolerate one medication better than the other depending on their symptoms and health history. Your healthcare provider will determine which option is most appropriate for your treatment plan.
Yes, olanzapine is the generic equivalent of Zyprexa. Both contain the same active ingredient and are used to treat psychiatric conditions such as schizophrenia and bipolar disorder. Generic and brand-name versions are considered therapeutically equivalent when used as prescribed.
Yes, olanzapine may sometimes be combined with mood stabilizers under psychiatric supervision, particularly in bipolar disorder treatment plans. Combination therapy may help improve mood stability and symptom control in certain individuals. Your healthcare provider will determine the safest and most effective medication regimen for your condition.
Disclaimer
The information provided on this page is for general informational purposes only and is not intended as medical advice. Always consult with a licensed healthcare provider before starting, stopping, or changing any medication regimen. While Invictus strives to provide accurate and up-to-date information, individual health conditions and circumstances vary. The prices, availability, and descriptions of all medications on this page are subject to change.
Your Prescription
Ready to Fill
